Fri, Apr 19, 2024
Whatsapp

Coronavirus India update: 80 crore vaccine doses for adults likely by December

Written by  Jasleen Kaur -- August 23rd 2021 06:07 PM -- Updated: August 23rd 2021 06:17 PM
Coronavirus India update: 80 crore vaccine doses for adults likely by December

Coronavirus India update: 80 crore vaccine doses for adults likely by December

Coronavirus India update: Covid vaccine production in India is ramped up and the country is likely to get 80 crore Covid-19 vaccine doses for adults between September and December this year, said Prof Narendra Kumar Arora, co-chair of COVAX facility — the international vaccine-sharing initiative, here on Monday. The government aims at administering one crore doses per day, and its expected coronavirus vaccine availability between August and December is about 135 crore doses. “As the production is ramped up and availability is increased, we are expecting to deliver 20 crore monthly doses in September, 25 crore in October, and 35 crore each in November and December,” says an expert. Also read | Actress Mahika Sharma trolled over her wish to tie 'rakhi' to Taliban fighters As per reports, vaccine acceptance in India is among the highest in the world. As per the latest coronavirus update, the country has “invested more than Rs 2,000 crore in vaccine production in the past one-and-a-half years, is the largest vaccine producers in the world". India May Get 80 Crore Covid-19 Vaccine Doses By December' | Nation According to the Union Health Ministry’s latest provisional report, more than 7.95 lakh vaccine doses have been administered in India on August 22, taking the total number of vaccine doses administered so far to 58.25 crore. Also read | India’s first smog tower comes up in Delhi; all you need to know India currently has four vaccines approved for use: Oxford-AstraZeneca’s Covishield, manufactured by the Serum Institute of India (SII), Bharat Biotech’s Covaxin, Sputnik and Zydus Cadila’s ZyCoV-D. ZyCoV-D, the world’s first DNA vaccine against Covid, is the second home-grown shot after Covaxin. Biological-E Gets Deal With Centre To Make 30 Crore Doses of Second Made-in-India COVID Vaccine Meanwhile, India also aims to roll out vaccines for children in the 12-18 age group by September. -PTC News with inputs from graphics


Top News view more...

Latest News view more...